LCT Receives Ethics Approval for Phase IIb Parkinson's Trial
Go back to LCT Receives Ethics Approval for Phase IIb Parkinson's Trial| Collectors Universe (NASDAQ: LCT) | Delayed: 0.79 +0.18 (29.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.61 | 52 Week High | $0.79 | |||
| Open | $0.71 | 52 Week Low | $0.70 | |||
| Day High | $0.79 | P/E | N/A | |||
| Day Low | $0.70 | EPS | $-0.30 | |||
| Volume | 2,760 | |||||
| Living Cell Technologies Ltd Sponsored ADR (AMEX: LVCLY) | Delayed: 0.03 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.03 | 52 Week High | $0.82 | |||
| Open | $0.03 | 52 Week Low | $0.23 | |||
| Day High | $0.03 | P/E | N/A | |||
| Day Low | $0.03 | EPS | $0.00 | |||
| Volume | 253 | |||||
